CRANFORD, N.J., Aug. 29, 2019 /PRNewswire/ -- Citius
Pharmaceuticals, Inc. ("Citius") (Nasdaq: CTXR), a specialty
pharmaceutical company focused on adjunctive cancer care and
critical care drug products, announced today that the Company
will be presenting at the 4th annual Disruptive Growth
Conference on Wednesday, September 4th at
3:40PM EST in Presentation Room A/B.
During the conference, Executive Chairman, Mr. Leonard Mazur will be giving the presentation as
well as answering questions from investors.
Citius Pharmaceuticals, Inc. will also be available for
one-on-one meetings. To arrange a meeting with the Company, please
contact Mr. Andrew Scott:
ascott@citiuspharma.com.
The 2018 Disruptive Growth Conference will offer the exclusive
opportunity to discover growth companies with disruptive
technologies and business models covering the following sectors:
communications, consumer, energy/alternative energy, healthcare,
industrial, life sciences, natural resources, and technology.
About Citius Pharmaceuticals, Inc.
Citius is a
specialty pharmaceutical company dedicated to the development and
commercialization of critical care products, with a focus on
anti-infectives, cancer care and unique prescription products that
use innovative, patented or proprietary formulations of
previously-approved active pharmaceutical ingredients. We seek to
achieve leading market positions by providing therapeutic products
that address unmet medical needs; by using previously approved
drugs with substantial safety and efficacy data, we seek to reduce
the risks associated with pharmaceutical product development and
regulatory requirements. Citius develops products that have
intellectual property protection and competitive advantages to
existing therapeutic approaches. For more information, please visit
www.citiuspharma.com.
About RHK Capital:
Advisory Group Equity Services,
Ltd. (dba RHK Capital) was founded in 1984. RHK Capital is a
boutique investment banking firm specializing in small to
medium-sized transactions. RHK is led by a management team with
extensive financial industry experience and a desire to provide
companies and individuals with the tools and expertise to
accomplish their financial goals. In addition to investment
banking, RHK has grown to include businesses in general
securities, emerging market securities, distressed and high yield
debt securities, investment management, mortgages, and business
lending. As a division of Advisory Group Equity Services (AGES),
all securities are offered through Advisory Group Equity Services
Ltd., a registered broker-dealer, member of the Financial Industry
Regulatory Authority and the Securities Investor Protection
Corporation.
About TAG Group:
AGES as part of the holding company
TAG Group, Inc., is a leading provider of estate, business and
financial services for high net worth individuals and business
entities. TAG maintains a comprehensive network of legal,
financial and accounting professionals who are committed to
providing the highest level of service to their clients. TAG
maintains three separate and distinct operating units under its
corporate umbrella, they are: Trust Advisory Group, Ltd., Advisory
Group Equity Services, Ltd., and Estate Insurance Services,
Ltd.
About Reed
Smith:
Reed Smith is a
dynamic international law firm dedicated to helping clients move
their businesses forward. Our long-standing relationships and
international outlook make us the go-to partner for speedy
resolution of complex transactions, disputes and regulatory
matters. At Reed Smith, we believe that the practice of law
has the ability to drive progress. We know your time is
valuable and your matters are important. We are focused on
outcomes, are highly collaborative, and have deep industry insight
that, when coupled with our local market knowledge, allows us to
anticipate and address your needs. You deserve purposeful, highly
engaged client service that drives progress for your business.
For those interested in attending, please visit
www.DisruptNYC.com for more information.
Contact:
Andrew
Scott
Vice President, Corporate Development
(o) 908-967-6677 x105
11 Commerce Drive, 1st Floor
Cranford, New Jersey 07016
ascott@citiuspharma.com
View original
content:http://www.prnewswire.com/news-releases/citius-pharmaceuticals-inc-to-present-at-the-rhk-capital-4th-annual-disruptive-growth-conference-hosted-by-reed-smith-300908736.html
SOURCE Citius Pharmaceuticals, Inc.